FutureLife, a pan-European IVF and genetics provider, has rolled out an AI platform across its 60 clinics in 16 countries through a partnership with US-based Alife Health, which modernises and personalises the IVF process using AI.
London-based private equity firm Columna Capital has acquired a majority stake in Evidenze Group, a pan-European outsourced pharma services company, from Madrid-based Buenavista Equity Partners.
This week I participated in a webinar hosted by the International Federation of Health Plans (iFHP), the main global trade body for private health insurers. The purpose of this was to present and discuss the Special Report we published on private medical insurance (PMI) in February, to an audience of iFHP’s members.
A panel entitled ‘Investing in the UK and Ireland’ at HBI’s 2026 conference discussed how the healthcare market in the UK and Ireland is being shaped by policy shifts, which include the latest 10-year plan from the National Health Service (NHS).
Private equity firm Nordic Capital-backed LEO Pharma, a provider of medical dermatology solutions, has acquired gene therapy company Replay, which develops gene therapies for rare genetic conditions
Replay’s equity holders will receive $50 million upfront, with additional milestone payments and tiered single-digit royalties.
At HBI 2026, healthcare investors and operators discussed what separates healthcare platforms that scale successfully from those that struggle, focusing on buy-and-build strategies, operational discipline and international expansion.
European healthtech group Doctolib has entered the UK market through the acquisition of London-based startup Medicus. The company plans to invest over £100 million (~$136 million) in the UK as part of its expansion.
Healthcare systems across Europe are under sustained pressure from ageing populations, chronic disease, staff shortages, and rising patient expectations. Traditional care models are struggling to keep up. At the same time, digital health and AI are advancing rapidly. The core challenge is not a lack of innovation, but overcoming barriers to scaling solutions across fragmented healthcare systems.
Speakers at HBI 2026 discussed how data is “not about simple dashboards”, but is something that can shape investment decisions, sometimes in a way that runs counter to intuition, on a panel entitled 'Building customer growth engines; The power of data and KPIs to drive investment decisions'.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.